Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000472892 | SCV000563182 | benign | not provided | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313239 | SCV000849091 | likely benign | Inborn genetic diseases | 2016-12-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000472892 | SCV001748140 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | SZT2: BP4, BP7 |
Gene |
RCV000472892 | SCV001822482 | likely benign | not provided | 2020-12-16 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003457706 | SCV004178751 | benign | Developmental and epileptic encephalopathy, 18 | 2023-04-11 | criteria provided, single submitter | clinical testing |